SMA OneTouch ICS
The SMA OneTouch ICS is a computerized, automated, viable air monitoring system that controls, calibrated and precise air sampling through individual or multiple SMA Atriums®. The SMA OneTouch ICS offers fully integrated, real-time control and monitoring of every individual sampling point, you will have the complete confidence that all viable sampling is being performed accurately and effectively. Sample parameters include facility wide, sample volume, sample duration, and vacuum pump status, all of which can be directly monitored on one single interface.
The ICS installation requires minimal tubing and wiring therefore simplifying installation into new and existing facilities. Additional features include, remote monitoring by using a variety of handheld, tablet, or computerized based devises and sounds immediate audible and visual alarms if the sample is compromised or aborted. It is, assuredly, the most comprehensive monitoring system in the industry. Click here For more details.
Contact Details :
Veltek Associates, Inc.
Website: www.sterile.com
E-mail: vai@sterile.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
